mainstay

Mainstay Medical announces half year financial results

on 28/08/2014 16:20

Momentum builds towards commercialisation of ReActiv8®
Read more

Mainstay Medical Announces Pre-IDE Submission for ReActiv8® to FDA

on 07/07/2014 11:26

Mainstay Medical continues progress towards the commercialisation of ReActiv8.
Read more

Mainstay Medical to Euronext and Irish Stock Exchange

on 28/04/2014 17:35

Announcement of offer price and number of issued ordinary shares on admission to Euronext Paris and ESM.
Read more

Capricorn Health-tech Fund makes its fourth investment

on 26/09/2012 11:27

Mainstay Medical completes € 15.3 million oversubscribed series B venture financing
Read more